| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2023 |
4
| Odence-Ford Marion (General Counsel and CCO) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Paid exercise price by delivering 1,952 shares
@ $7.06, valued at
$13.8k
Exercised 6,649 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Silvestro Stephen L (Chief Commercial Officer) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Paid exercise price by delivering 1,952 shares
@ $7.06, valued at
$13.8k
Exercised 6,649 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Stelmakh Edward (CFO/COO) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Paid exercise price by delivering 4,117 shares
@ $7.06, valued at
$29.1k
Exercised 16,662 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Besch Doug (Chief Product Officer) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Paid exercise price by delivering 976 shares
@ $7.06, valued at
$6.9k
Exercised 3,324 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| HALAS GUS D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 4,637 restricted stock units
@ $0
Granted 10,061 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| Spangler Patrick D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 4,637 restricted stock units
@ $0
Granted 10,061 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| WASSON GREGORY D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 4,637 restricted stock units
@ $0
Granted 10,061 restricted stock units
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Lang James Paul (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 657 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| HALAS GUS D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 657 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| WASSON GREGORY D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 657 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| Spangler Patrick D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 657 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| Vos Ellen O'Connor (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 657 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Odence-Ford Marion (General Counsel and CCO) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Paid exercise price by delivering 1,422 shares
@ $17.34, valued at
$24.7k
Exercised 4,000 restricted stock units
@ $0 |
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| HALAS GUS D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 409 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| WASSON GREGORY D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 409 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Vos Ellen O'Connor (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 409 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Spangler Patrick D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 409 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Lang James Paul (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 409 restricted stock units
@ $0 |
|
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
3
| Besch Doug (Chief Product Officer) has filed a Form 3 on OptimizeRx Corp |
| 09/30/2022 |
4
| Spangler Patrick D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 334 restricted stock units
@ $0 |
|
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| HALAS GUS D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 334 restricted stock units
@ $0 |
|
| 09/30/2022 |
4
| WASSON GREGORY D (Director) has filed a Form 4 on OptimizeRx Corp|
Txns:
| Exercised 334 restricted stock units
@ $0 |
|
|